Iovance Biotherapeutics Inc
SWB:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
J
|
Jiangsu Expressway Co Ltd
OTC:JEXYY
|
CN |
|
Ulta Beauty Inc
NASDAQ:ULTA
|
US |
|
F
|
Fairfax Financial Holdings Ltd
LSE:0KV5
|
CA |
|
A
|
Auckland International Airport Ltd
F:BZTA
|
NZ |
|
Anglo American Platinum Ltd
F:RPHA
|
ZA |
|
SEGRO PLC
LSE:SGRO
|
UK |
|
Pernod Ricard SA
F:PER0
|
FR |
|
Next PLC
LSE:NXT
|
UK |
|
Aspen Pharmacare Holdings Ltd
F:LDZA
|
ZA |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
R
|
Rojana Industrial Park PCL
SET:ROJNA
|
TH |
|
G
|
General Motors Co
F:8GM
|
US |
|
Gale Pacific Ltd
ASX:GAP
|
AU |
|
A
|
Adidas AG
XHAN:ADS
|
DE |
|
Indian Oil Corporation Ltd
NSE:IOC
|
IN |
|
ALSOK Co Ltd
TSE:2331
|
JP |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
Weatherford International PLC
NASDAQ:WFRD
|
US |
Bankruptcy Probability
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Iovance Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
4.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
50.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Iovance Biotherapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.